ライフサイエンスコーパス: general practice

1 w-up adjusted for sex, 5-year age group, and general practice.

2 patient-facing clinical workload in English general practice.

3 for general practitioner consultations in UK general practice.

4 Both groups were stratified by general practice.

5 effectiveness of targeted immunization as a general practice.

6 ns will encounter children with IBD in their general practice.

7 ajority (54%) of the patients were tested in general practice.

8 es are required to allow recommendations for general practice.

9 nce was computer-generated and stratified by general practice.

10 een 2 and 21 years' experience of working in general practice.

11 ED visits by the registered population of a general practice.

12 y before these results are incorporated into general practice.

13 uch medication related potential for harm in general practice.

14 d omeprazole (20 mg/day) on GERD symptoms in general practice.

15 mary prevention and early diagnosis of HF in general practice.

16 ex-matched controls without ITP recruited in general practice.

17 nce in the electronic medical records of the general practice.

18 01 with up to five controls by age, sex, and general practice.

19 for age, sex, deprivation, and clustering by general practice.

20 treatments are not routinely implemented in general practice.

21 Controls were matched on age, sex, and general practice.

22 s to improve translation of trial results to general practice.

23 health check, were matched for age, sex, and general practice.

24 history of cancer, matched for age, sex, and general practice.

25 caries-free children aged 2 to 3 y attending general practice.

26 patients without psoriasis on age, sex, and general practice.

27 mentia diagnosis and patient presentation to general practice.

28 igibility and recruited 424 patients from 95 general practices.

29 nary heart disease Registers in South London General Practices.

30 [ICD]-10 criteria for depression) from 73 UK general practices.

31 bing and inadequate blood-test monitoring in general practices.

32 o all adults age >30 years registered with 2 general practices.

33 th high-dose opioid prescribing behaviour in general practices.

34 IMD), and nested using random effects within general practices.

35 This laboratory serves four hospitals and 75 general practices.

36 omised controlled trial involving 45 English general practices.

37 om 49 intervention (n=23) and control (n=26) general practices; 149 participants per group comprised

38 317 of these general practices (157 in the routine care group, 161 in

39 at one of 2 Melbourne, Victoria, Australia, general practices (2007-2013).

40 .4%; internal medicine, 27.5%; and family or general practice, 21.1%).

41 a cluster-randomised factorial trial in 106 general practices (43219 eligible patients aged 75 years

42 iated with increased visits to physicians in general practice (6.6 percentage points [CI, 1.3 to 12.0

43 led trial with randomization at the level of general practices (73 in each of two arms) in the Centra

44 ealth providers and patients from Australian general practice, Aboriginal community-controlled and go

45 Using 2012 and 2013 QOF data from 9731 general practices across all four countries in the UK, w

46 holds data from 753 National Health Service general practices across England.

47 803 persons 70 years of age or older from 63 general practices across England: 3223 were assigned to

48 ver 32 million patients from more than 1,500 general practices across the UK.

49 a computerized primary care database of 177 general practices across the United Kingdom; 8778 cases

50 tative sample of 164 primary care practices (general practices) across England.

51 General practices actively participating in the programm

52 with a high density of migrants, of which 63 general practices agreed to participate.

53 40 of 45 (89%) general practices agreed to participate: 20 were assigne

54 Stricter targets in general practice and further measures to motivate patien

55 Authorities, Department of Health, academia, General Practice and Hospital Trusts and the third secto

56 Hospital, general practice and laboratory records were searched to

57 A general practice and public health perspective favors th

58 r the previous year; visits to physicians in general practice and specialists; hospitalizations and e

59 care has emerged at the forefront of several general practice and subspecialty guidelines and is the

60 ethotrexate is a commonly prescribed drug in general practice and when used in NMO it reduces relapse

61 HCPs (doctors/nurses in general practice and/or hospital) were regarded by patie

62 15 general practices and 7012 patients receiving the nurse

63 regression to account for clustering within general practices and adjusting for other key variables.

64 General practices and community clinics were randomised

65 effectiveness (cost-utility) trial across 27 general practices and community musculoskeletal services

66 D3 supplementation in adults with COPD in 60 general practices and four Acute National Health Service

67 eople aged over 40, who were registered with general practices and had been exposed to the death of a

68 ) were identified from medical records in 99 general practices and invited to participate by their ge

69 chronic low-back pain were recruited from 56 general practices and received an active management advi

70 ited by letter and opportunistically from 74 general practices and three gastroenterology centres in

71 es > or =50 years who were registered with 3 general practices and were experiencing knee pain within

72 ld) with atopic eczema matched (by age, sex, general practice, and cohort entry date) with up to 5 in

73 ioverter-defibrillator (ICD) implantation in general practice, and estimate the incremental costs of

74 of 12, with stratification by trial centre, general practice, and household type.

75 locks of 12, and stratified by trial centre, general practice, and household type.

76 0 controls matched to the cases by age, sex, general practice, and time in the cohort were selected.

77 ,025 controls matched by year of birth, sex, general practice, and years of medical records before th

78 ek follow-up at 100 sites (hospital clinics, general practices, and clinical research centers) in 14

79 ments and investigated the risk of missing a general practice appointment using a negative binomial m

80 Individual-level patterns of missed general practice appointments might thus provide a risk

81 racteristics contribute to non-attendance of general practice appointments raise important questions

82 ractice factors to the likelihood of missing general practice appointments.

83 Clinical scoring systems that may be used in general practice as initial screening tools also may pro

84 nd cause of death and registered at the same general practices as those with intellectual disabilitie

85 burden of work for physicians and nurses in general practice associated with newly diagnosed dementi

86 We recruited 22 general practices (August 2013-September 2014) and 13 co

87 CC3 genotype was investigated using PCR in a general-practice-based sample of 565 women and 475 patie

88 temporary patients registered at 398 English general practices between April, 2007, and March, 2014.

89 There is growing concern that many general practices cannot respond to new expectations.

90 s, which are accessible by all hospitals and general practices caring for coronary and high-risk pati

91 A prospective study conducted in a Thai general practice clinic demonstrated a high prevalence (

92 Randomisation was done both at the general practice clinic level (cluster randomisation) an

93 as done in 109 socio-demographically diverse general practice clinics in England.

94 ontrolled, two-arm effectiveness trial at 74 general practice clinics in Salford and South Manchester

95 r diabetes or family history registers at 20 general practice clinics in the UK.

96 patients were randomly assigned (1:1) by the general practice clinics using a centrally prepared comp

97 ween March 20, 2017, and March 21, 2019, 113 general practice clinics were enrolled, but four clinics

98 General practice clinics were selected by the local clin

99 In a large general-practice cohort of patients with multiple cardio

100 en February and March 2015, we recruited 144 general practices collectively serving over 1 million pa

101 nts registered between 1990 and 2008 at U.K. general practices contributing to The Health Improvement

102 ses and symptoms were calculated from 361 UK general practices contributing to The Health Improvement

103 ith individuals without BE for age, sex, and general practice (controls, N = 155,212).

104 ged less than 45 years randomly sampled from general practices countrywide.

105 It was implemented in 43 general practices covering a population of 235,595 peopl

106 gic Research, Danish Research Foundation for General Practice, Danish Centre for Evaluation and Healt

107 sis, we extracted UK National Health Service general practice data that were routinely collected acro

108 This is the first study to use general practice data to examine the overall health of P

109 Using a national UK general practice database linked to hospitalizations (19

110 ovement Network, a large population-based UK general practice database, were used to conduct a matche

111 cataract-free controls matched on age, sex, general practice, date of cataract recording (i.e., inde

112 igate the extent to which periodontists' and general practice dentists' (GPs) behaviors and attitudes

113 Five UK General practices each sent the PFSDQ2 by post to 2000 p

114 bing people's stories; trial 3 (June, 2013), general practice endorsement of the programme on the inv

115 isk scoring methods are to be widely used in general practice, evidence is required on both the accur

116 ged >/=65 years with dementia in 87 Scottish general practices, examining the impact of two pre-speci

117 ex date), matched by year of birth, sex, and general practice for a control to case ratio of 4 to 1.

118 tics linkage, and were registered with their general practice for at least 12 months.

119 er allergy assessment and tailored advice in general practice for patients with asthma and rhinitis e

120 indicators were examined using data from 76 general practices for 2009-2010 in a large primary care

121 rally sensitive, enhanced care package in UK general practices for improvement of cardiovascular risk

122 issioning Groups in England, containing 7821 general practices for the geographical analysis.

123 ed >/=35 years and matched for sex, age, and general practice from the United Kingdom Clinical Practi

124 As previously described, general practices from four centres (Denmark, Cambridge

125 solated from patients registered to the same general practice (GP) surgery.

126 Using data from GUM clinics and a sample of general practices (GPs) throughout England, we analyzed

127 Health professionals from general practices (GPs) who signed up to LES were given

128 according to baseline BDI score, whether the general practice had a counsellor, previous treatment wi

129 Our cohort of 1,958,191 people from UK general practices had a median age at baseline of 55 yea

130 ypes of bariatric surgery based on data from general practice has not been carried out.

131 ibular rehabilitation delivered by nurses in general practice improves symptoms, postural stability,

132 lts, we designed a clinical flow diagram for general practice in detecting recurrent MTC.

133 ears) who were permanently registered with a general practice in three defined geographical areas (Ca

134 stroke, or diabetes and who were drawn from general practices in 24 British towns.

135 ase, stroke, or diabetes who were drawn from general practices in 24 British towns.

136 cular disease and cancer and were drawn from general practices in 24 British towns.

137 study at hospitals, minor injury units, and general practices in and around 4 UK study centers.

138 open, cluster-randomised controlled trial in general practices in areas of the UK with a high density

139 recommend implementation of HIV screening in general practices in areas with high HIV prevalence.

140 agnosis of depression were recruited from 55 general practices in Bristol, London, and Warwickshire,

141 parallel group, cluster-randomised trial, 33 general practices in eastern England were randomly assig

142 als aged 40-74 years and registered with 455 general practices in England (January 2009-May 2016).

143 years without CRC were identified from three General Practices in England (two in Cumbria, one in Lon

144 tively healthy adults, aged 70-79 y, from 20 general practices in England and Wales were randomly ass

145 without radiculopathy) consultations at ten general practices in England responded to invitations to

146 d analysis of patients registered with 7,856 general practices in England was conducted, for the time

147 lly from clinical computing systems for 7637 general practices in England, data from the UK census, a

148 ing a household by mailed invitation through general practices in England.

149 f 2-8 weeks' duration were recruited from 25 general practices in England.

150 ing open data sources on prescribing for all general practices in England.

151 Simple 1:1 randomization of general practices in Germany was used.

152 We randomised 51 (61%) of 84 eligible general practices in Hackney and Bristol.

153 trial, we randomised 50 of 52 (96%) eligible general practices in Hackney, London, UK, to receive an

154 ction and the effect of screening for HIV in general practices in Hackney.

155 duals (age > or =50 years) registered with 3 general practices in North Staffordshire in the UK.

156 nd, randomised controlled trial, we included general practices in Scotland, UK.

157 RTIs among children aged 0-12 years from all general practices in the Clinical Practice Research Data

158 Participants were registered with general practices in the Clinical Practice Research Data

159 In general practices in the intervention groups, angiotensi

160 12 General Practices in the Northwest of England located wi

161 ta covering the entire Danish population and general practices in the UK Clinical Practice Research D

162 financial incentive scheme that remunerates general practices in the UK for their performance agains

163 In this pragmatic, cluster randomised trial general practices in the UK were stratified by research

164 omised controlled trial was undertaken in 24 general practices in the UK.

165 rom a population of 253,618 patients from 42 general practices in the UK.

166 trolled trial, we recruited patients from 34 general practices in the UK.

167 udy including all registered patients at 706 general practices in the United Kingdom Clinical Practic

168 More than 650 general practices in the United Kingdom contributing to

169 case-control study was conducted within 454 general practices in the United Kingdom using the QRESEA

170 f consecutive back pain consulters from five general practices in the United Kingdom was carried out

171 r-randomised controlled trial, participating general practices in the West Midlands, UK, were randoml

172 ividuals aged at least 40 years attending 26 general practices in three areas of England between Dec

173 ed trial with participants recruited from 43 general practices in three areas of England.

174 We approached 70 general practices in three areas with a high density of

175 a randomised controlled trial done across 73 general practices in three UK centres.

176 ter randomised controlled trial, we selected general practices in two urban primary care trusts, Hack

177 intenance antidepressants, from primary care general practices in urban and rural settings in the UK.

178 s using balanced incomplete block designs in general practices in West Yorkshire, England.

179 sing individual randomisation, stratified by general practice, in a 1:2 ratio, to yearly mammographic

180 mending adoption of lung cancer screening in general practice is premature.

181 However, regardless of stage, general practice is to treat patients based on limited (

182 Promotion of opt-out rapid testing in general practice led to increased rate of diagnosis, and

183 Our Liaison and Education in General Practices (LEGs) study was a cluster-randomised

184 General practice, long considered the jewel in the crown

185 iderable variation in data recording between general practices (missingness of body mass index ranged

186 in both modes demonstrate that, contrary to general practice, negative mode allows better sensitivit

187 gic Research, Danish Research Foundation for General Practice, Novo Nordisk, Novo Nordisk Foundation,

188 asing incidence that is commonly seen in the general practice of nephrology.

189 s (alive and registered with a participating general practice on 24 September 2009).

190 test for lifetime risk of prostate cancer in general practice on future PSA testing.

191 ber of persons registered with participating general practices on that same date.

192 atasets (Clinical Practice Research Datalink General Practice OnLine Database linked with Hospital Ep

193 d data from 796,594 population-based English General Practice Patient Survey responders to explore th

194 t 5 years was more commonly reported by male General Practice Patient Survey responders who endorsed

195 The allocation was not masked to general practices, pharmacists, patients, or researchers

196 ospective survey of specimens submitted from general practice, private specialists, and hospitals to

197 General practices provided lists of individuals to be co

198 General practices providing more timely access to primar

199 ter-randomised controlled trial including 43 general practices randomised to receive either standard

200 and GORD in menopausal women using validated general practice records.

201 was composed using primary care records from general practice registration networks (GPRNs) across th

202 orectal cancer-free initial follow-up in the General Practice Research Database (1987-2002) from the

203 d case-control study was conducted using the General Practice Research Database (1987-2003), which co

204 s claims database) from 1998-2002 and the UK General Practice Research Database (GPRD) between 1990-2

205 multiple sclerosis diagnosis recorded in the General Practice Research Database (GPRD) between Januar

206 The UK General Practice Research Database (GPRD) contains the c

207 is is a retrospective cohort study using the General Practice Research Database (GPRD) from the Unite

208 32,973 matched controls, extracted from the General Practice Research Database (GPRD) over the perio

209 The United Kingdom General Practice Research Database (GPRD) was used to id

210 The study was carried out in the General Practice Research Database (GPRD), a primary car

211 ish Hospital Episodes Statistics (HES) data, General Practice Research Database (GPRD), and Office of

212 The study was based on the UK General Practice Research Database (GPRD), which covers

213 controls identified from 1990 to 2005 in the General Practice Research Database (GPRD).

214 with data from Jan 1, 1990 to Dec 31, 2009 (General Practice Research Database and Optimum Patient C

215 e patient's medical record and stored in the General Practice Research Database between 1987 and 2002

216 enopausal women were identified using the UK General Practice Research Database between 1995-2004.

217 omen with asthma were identified from the UK General Practice Research Database between 2000 and 2008

218 rol study nested in the United Kingdom-based General Practice Research Database cohort, the authors i

219 We identified all individuals in the UK General Practice Research Database diagnosed with esopha

220 enzalike illness using cases recorded in the General Practice Research Database from 1990 to 2005 in

221 h type 2 diabetes were generated from the UK General Practice Research Database from November 1986 to

222 diagnosis of type 2 diabetes mellitus in the General Practice Research Database from the United Kingd

223 y general practitioners participating in the General Practice Research Database in the United Kingdom

224 cases identified during 1990-2001 using the General Practice Research Database in the United Kingdom

225 esigns free of any immortal time bias in the General Practice Research Database in the United Kingdom

226 UK General Practice Research Database Pregnancies ending in

227 Data were extracted from the UK General Practice Research Database to compare the incide

228 We used 1988 to 1997 data from the General Practice Research Database to conduct a retrospe

229 We have performed a cohort study using the General Practice Research Database to quantify the exces

230 All patients in the UK General Practice Research Database undergoing a THR for

231 The General Practice Research database was analyzed to ident

232 The General Practice Research Database was used to identify

233 We selected subjects within the General Practice Research Database with a coded diagnosi

234 using computerized medical records from the General Practice Research Database, a large representati

235 nts with RA ages >or=40 years in the British General Practice Research Database, each matched by age,

236 Among patients in the UK General Practice Research Database, the use of oral bisp

237 cohort studies, utilizing the United Kingdom General Practice Research Database, to assess intraindiv

238 Using the General Practice Research Database, we estimate the inci

239 From the General Practice Research Database, we matched patients

240 control study using the United Kingdom-based General Practice Research Database, we tested the hypoth

241 The study was based on the United Kingdom General Practice Research Database, which contains compu

242 January 2000 through November 2009 using the General Practice Research Database.

243 iagnoses of HD, were retrieved from the UK's General Practice Research Database.

244 76) in 1999 and 2007 were extracted from the General Practice Research Database.

245 tudinal cohort study was conducted in the UK General Practice Research Database.

246 and 2007 (n=13 330) were extracted from the General Practice Research Database.

247 Data were drawn from the UK General Practice Research Database.

248 ial Ischaemia National Audit Project and the General Practice Research Database.

249 m 197 family practices in the United Kingdom General Practice Research Database.

250 of lymphoma in psoriasis patients using the General Practice Research Database.

251 ional study using 1988 to 1997 data from the General Practice Research Database.

252 id a matched case-control study using the UK General Practice Research Database.

253 rs when designing future trials and refining general practice screening guidelines.

254 In the eight control general practices, screening was taken up by 543 (1.7%)

255 were measures of patient-reported access to general practice services; these were entered into a neg

256 is of melanoma occurred more frequently in a general practice setting and less frequently in direct c

257 patients without a history of epilepsy in a general practice setting using Clinical Practice Researc

258 atment of nonvalvular atrial fibrillation in general practice settings has not been established.

259 In general practice settings, dabigatran was associated wit

260 internal medicine specialists and family or general practice specialists were more likely to have gu

261 randomised controlled trial was delivered to general practice staff.

262 The National General Practice Study of Epilepsy and other studies hav

263 The National General Practice Study of Epilepsy is a prospective stud

264 The UK National General Practice Study of Epilepsy is a prospective, pop

265 ies and focuses particularly on the National General Practice Study of Epilepsy, a prospective popula

266 iagnosis and management of asthma and define general practices that meet the needs of most patients.

267 However, in the 50 general practices that used the intervention, screening

268 tiative for Asthma severity stages 1-5) from general practices, the databases of chest physicians, an

269 UK electronic medical records taken from 787 general practices throughout the UK.

270 cases and 2,193 poisoning cases, matched on general practice to 94,620 control children.

271 eshire Incidence of Parkinson's disease from General Practice to Neurologist and Parkinsonism: Incide

272 ied and matched on age, diabetes status, and general practice to up to four unexposed controls.

273 mber, 2011, we randomly assigned (1:1) these general practices to either health checks plus standard

274 introduction of health insurance systems or general practice, took into account political issues mor

275 computerized morbidity indices of 2 large UK general practices, total population 22,500.

276 ntrols to each case patient by age, sex, and general practice (United Kingdom only) using risk-set sa

277 recommended that TBTs should not be used in general practice until they are shown to have analytical

278 s in the first 2000 US patients implanted in general practice use.

279 r patient 'same-day' appointment requests in general practice using multivariable logistic regression

280 on disorders and mortality in Persians under general practice veterinary care in 2013 in the UK.

281 ntrolled effectiveness trial conducted in 75 general practices, we randomly assigned 2799 patients wi

282 ies, six pairs of hospitals and six pairs of general practices were assigned to an intervention progr

283 atients aged 40-89 years registered with 205 general practices were followed from 2003-2007.

284 ed controlled trial in Hackney (London, UK), general practices were randomly assigned (1:1) to offer

285 General practices were randomly assigned (1:2:2:2:2) to

286 Eight general practices were randomly assigned (stratified by

287 14, 74 818 eligible patients from 54 diverse general practices were randomly assigned and completed t

288 in Denmark, the Netherlands, and the UK, 343 general practices were randomly assigned screening of re

289 343 general practices were randomly assigned to routine diab

290 (date of the first diagnosed fracture), and general practice, were randomly selected for each case.

291 Data were obtained from records from general practices who had registered patients with the U

292 those without such read codes) from the same general practice, who were matched by age and sex.

293 ho were diagnosed with active asthma from UK general practice with linked secondary care data.

294 ntral web-based system and was stratified by general practice with minimisation for sex, baseline sys

295 FINDINGS: 72 general practices with a combined list size of 480,942 p

296 osen at the time of psoriasis diagnosis from general practices with at least one case, excluding chil

297 for reducing a range of medication errors in general practices with computerised clinical records.

298 sk score between individuals registered with general practices with different levels (tertiles) of pr

299 Set in 13 general practices within central England.

300 ion programme promoting rapid HIV testing in general practice would lead to increased and earlier HIV